MedMelior Inc. is a life sciences company creating and clinically validating an evolving intellectual property portfolio of novel molecules and drug delivery mechanisms for clinical trials and commercialization.
Jalid Sehouli is a gynecologist and oncologist specializing in ovarian, peritoneal and fallopian tube cancer, as well as a university lecturer and writer.
Sehouli's specialty is experimental surgical gynecology and oncosurgery, as well as physician-patient communication (Breaking Bad News). Sehouli is co-editor of several journals and author (first, senior and co-author) of several hundred articles in national and international journals on all aspects of gynecology and focus on diagnosis, treatment and follow-up of female cancers (Gynecologic Oncology). He is principal investigator of several national and international phase I, II, III trials of targeted therapies.